Top Page
Marlowe
(LSE:MRL)
Marlowe (MRL) vs. S&P 500 (SPY)
Marlowe Business Overview & Revenue Model
Marlowe Financial Statement Overview
| Breakdown | ||||
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|
| Income Statement | Total Revenue | |||
| 402.90M | 465.70M | 315.90M | 192.00M | 185.40M | Gross Profit |
| 151.60M | 149.90M | 113.50M | 67.90M | 65.40M | EBIT |
| -5.00M | 38.60M | 23.50M | 9.00M | 10.70M | EBITDA |
| 41.10M | 44.20M | 37.10M | 24.40M | 21.40M | Net Income Common Stockholders |
| -10.20M | -3.80M | 700.00K | -1.70M | -400.00K |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
| -2.30M | 30.20M | 31.20M | 44.20M | 7.20M | Total Assets |
| 890.30M | 851.40M | 791.20M | 383.60M | 210.30M | Total Debt |
| 258.10M | 219.10M | 164.50M | 19.90M | 53.80M | Net Debt |
| 258.10M | 188.90M | 133.30M | -24.30M | 46.60M | Total Liabilities |
| 452.80M | 408.10M | 345.20M | 120.20M | 113.60M | Stockholders Equity |
| 437.50M | 443.30M | 446.00M | 263.40M | 96.70M |
| Cash Flow | Free Cash Flow | |||
| 23.60M | 17.20M | -500.00K | 15.90M | 500.00K | Operating Cash Flow |
| 38.00M | 33.60M | 8.60M | 20.40M | 3.40M | Investing Cash Flow |
| -40.40M | -74.00M | -324.00M | -71.90M | -21.80M | Financing Cash Flow |
| 1.60M | 39.40M | 302.40M | 88.50M | 17.90M |
Marlowe Technical Analysis
Marlowe Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | $71.72B | 37.50 | 56.34% | 1.51% | 2.98% | 10.10% | |
78 Outperform | £11.88B | 37.80 | 25.84% | 1.69% | 6.78% | 55.05% | |
66 Neutral | £455.60M | 9.63 | 5.03% | 10.11% | -2.13% | ― | |
62 Neutral | $8.05B | 13.61 | 3.91% | 3.11% | 3.81% | -13.91% | |
59 Neutral | £1.87B | 19.14 | 11.07% | 2.96% | 4.71% | 0.43% | |
54 Neutral | £262.74M | ― | -0.67% | ― | -38.62% | 68.14% |
Marlowe Corporate Events
Marlowe plc has executed a share buyback program, purchasing 35,000 ordinary shares at a volume-weighted average price of 324.00 pence per share. This move will reduce the total number of shares in circulation to 80,844,240, impacting shareholder calculations under the FCA’s Disclosure Guidance and Transparency Rules.
Marlowe plc has executed a share buyback program, purchasing 70,000 ordinary shares at an average price of 324.69 pence per share. The acquired shares will be cancelled, reducing the total number of shares in issue to 80,879,240. This move is part of Marlowe’s ongoing strategy to manage its capital structure and could impact shareholder calculations under the FCA’s Disclosure Guidance and Transparency Rules.
Marlowe plc has executed a share buyback program, purchasing 20,000 ordinary shares at a price of 325.00 pence per share. This move will result in the cancellation of these shares, leaving the company with 80,949,240 shares in issue. The share buyback is part of Marlowe’s strategy to manage its capital structure effectively, potentially enhancing shareholder value and reflecting confidence in its business operations.
Marlowe plc announced the purchase of 35,000 ordinary shares as part of its share buyback program, at a volume-weighted average price of 325.00 pence per share. This move will reduce the total number of shares in circulation to 80,969,240, potentially impacting shareholder calculations under the FCA’s Disclosure Guidance and Transparency Rules.
Marlowe plc announced the purchase of 15,000 ordinary shares at a price of 325.00 pence each as part of its share buyback program. This transaction, executed through Cavendish Capital Markets Limited, will lead to the cancellation of these shares, leaving the company with 81,004,240 shares in issue. This move is part of Marlowe’s ongoing strategy to manage its share capital effectively and could impact shareholder calculations under the FCA’s Disclosure Guidance and Transparency Rules.
Marlowe plc has executed a share buyback program, purchasing 25,000 ordinary shares at a price of 325.00 pence each, which will be subsequently cancelled. This action will result in Marlowe having 81,159,240 ordinary shares in issue, providing a new denominator for shareholders to calculate their interests under FCA rules.
Marlowe plc has announced its total voting rights as of February 28, 2025, which consist of 81,184,240 ordinary shares with voting rights. This information is crucial for shareholders to determine their interest or any changes in their interest under the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules.
Marlowe plc has announced the successful passing of a special resolution at its General Meeting, granting additional authority for the company to make market purchases of its own ordinary shares. This decision supports the conclusion of the share buyback program initiated in May 2024 and provides the board with greater flexibility in future capital allocation, which can impact its financial strategy and shareholder value.
Marlowe plc announced the purchase of 25,000 ordinary shares as part of its share buyback programme, with plans to cancel these shares, affecting the total shares in issue. This action is part of the company’s strategy to manage its capital structure and may influence stakeholder calculations under regulatory rules.
Marlowe PLC announced the repurchase of 65,000 ordinary shares as part of its ongoing share buyback program. This transaction, conducted through Cavendish Capital Markets Limited, reflects Marlowe’s commitment to optimizing its capital structure. The cancellation of these shares will adjust the total number of shares in issue, potentially affecting shareholder calculations under FCA rules.
Marlowe plc announced the repurchase of 60,000 ordinary shares at an average price of 324.96 pence as part of its ongoing share buyback programme. This transaction, executed through Cavendish Capital Markets Limited, will result in the cancellation of these shares, reducing the total number of shares in circulation to 81,274,240. This move is likely intended to enhance shareholder value and manage the company’s capital structure, reflecting Marlowe’s strategic financial management approach.
Marlowe plc has announced a proposal for additional authority to purchase its own ordinary shares, aiming to provide increased flexibility in capital allocation beyond its initial £75 million share buyback program. The company has called a general meeting on 20 February 2025 to seek shareholder approval for this special resolution, which reflects Marlowe’s strategic efforts to enhance its financial management and market positioning.
Marlowe plc has executed a share buyback, acquiring 450,000 ordinary shares at a volume-weighted average price of 324.63 pence per share. This action aligns with the company’s previously announced buyback program and will result in the cancellation of these shares, leaving Marlowe with a total of 81,334,240 shares in issue. This move is part of Marlowe’s strategy to manage its share capital and potentially enhance shareholder value.
Marlowe plc has announced its total voting rights as of January 31, 2025, comprising 81,784,240 ordinary shares with attached voting rights. This figure will aid shareholders in determining necessary notifications of interest according to FCA’s Disclosure Guidance and Transparency Rules, potentially impacting stakeholder decisions and company governance.
Marlowe plc has executed a share buyback program, purchasing 50,000 of its own shares at a volume-weighted average price of 320 pence per share. Following the cancellation of these shares, the company’s total issued shares will be reduced to 81,859,240. This move may impact shareholder calculations under the FCA’s Disclosure Guidance and Transparency Rules.
Marlowe plc has executed a share buyback, purchasing 50,000 of its own shares at a price of 320.00 pence each, as part of its announced programme. This transaction, handled by Cavendish Capital Markets Limited, is expected to result in the cancellation of the acquired shares, impacting the company’s total share count and potentially affecting shareholder calculations under FCA rules.
Marlowe plc has repurchased 152,500 of its own ordinary shares at an average price of 319.87 pence per share as part of its share buyback program initiated in May 2024. This transaction, which will lead to the cancellation of these shares, reduces the total number of shares in issue to 81,909,240, potentially impacting shareholder calculations under the FCA’s rules.
Marlowe plc announced the purchase of 65,122 ordinary shares as part of its share buyback program, initially announced in May 2024. The shares were bought at an average price of 319.88 pence each and will be canceled, leaving a total of 82,061,740 ordinary shares in issue. This share buyback is part of Marlowe’s strategy to manage its capital structure, potentially enhancing shareholder value and reflecting confidence in the company’s future prospects.
Marlowe plc has repurchased 119,708 ordinary shares at a price of 320 pence per share under its share buyback programme, with plans to cancel these shares. This move will reduce the total number of shares in circulation to 82,126,862, affecting shareholder calculations under FCA’s rules. The transaction reflects Marlowe’s ongoing strategy to optimize its capital structure and potentially increase shareholder value.
Marlowe plc announced the purchase of 68,694 of its own shares at a volume-weighted average price of 320.0 pence per share as part of its ongoing share buyback program. This move will reduce the number of ordinary shares in issue to 82,346,570, impacting shareholder calculations for interest notifications under the FCA’s rules.
Marlowe plc has announced the purchase of 15,593 of its own ordinary shares as part of its share buyback program, with plans to cancel these shares. This move follows previous buybacks in October 2024 of 150,000 and 120,000 shares, which have already been canceled. The company’s actions are aimed at managing its share capital and potentially enhancing shareholder value, with the current number of shares standing at 82,415,264. These transactions reflect Marlowe’s strategy to optimize its capital structure while maintaining transparency with stakeholders.
Marlowe plc has executed a share buyback, purchasing 146,683 ordinary shares at a price of 320 pence per share, as part of its ongoing program announced in May 2024. This move reduces the total number of shares in issue to 82,430,857, potentially impacting shareholder calculations regarding their interests under FCA rules.
Marlowe plc announced the repurchase of 28,522 ordinary shares at a volume-weighted average price of 319.9 pence per share as part of its share buyback programme. This move, executed through Cavendish Capital Markets Limited, will result in the shares being cancelled, reducing the total number of shares in circulation to 82,777,540. The repurchase and cancellation of shares are aimed at enhancing shareholder value and optimizing the company’s capital structure.
Marlowe plc has announced the purchase of 46,368 ordinary shares as part of its share buyback program at an average price of 320.0 pence per share. This transaction reduces the total number of shares in circulation to 82,806,062, which is significant for shareholders calculating their interest under regulatory guidelines.
Marlowe plc has executed a share buyback program, purchasing 75,000 ordinary shares at an average price of 319.90 pence each. The acquired shares will be canceled, resulting in a total of 82,852,430 shares remaining in issuance. This move is part of a previously announced program and may affect the calculations stakeholders use to determine their interest in the company according to FCA regulations.
Marlowe plc announced that Robert Flinn, CEO of its Fire Division, and his spouse have purchased a total of 15,527 ordinary shares, enhancing their stake in the company. This move reflects confidence in the company’s prospects and may positively influence market perception, potentially impacting stakeholders’ views on Marlowe’s future performance.
Marlowe PLC announced a notification of major holdings, revealing that UBS Group AG’s trading book holdings in the company have fallen below 5%, thereby exempting them from certain reporting obligations. This change marks a reduction in UBS’s voting rights in Marlowe PLC from a previous position of over 5% to 0%, potentially impacting the company’s shareholder structure and market perception.
Marlowe plc announced that as of 31 December 2024, its issued capital consists of 82,927,430 ordinary shares with attached voting rights, indicating no shares are held in Treasury. This information is crucial for shareholders to determine their notification requirements under the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules, potentially impacting stakeholder engagement and compliance obligations.
Marlowe plc announced the purchase of 25,000 of its own ordinary shares as part of its share buyback programme. This move, executed at a volume-weighted average price of 309.60 pence per share, will result in the cancellation of the acquired shares, leaving the company with 82,927,430 ordinary shares in issue. This buyback is expected to impact shareholder calculations regarding their interests in the company under FCA guidelines.